Lv12
10 积分 2026-04-27 加入
Safety and clinical outcomes of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune diseases
1小时前
已完结
A safety analysis of programmed death 1 pathway inhibitors in patients with solid tumor malignancies and preexisting autoimmune disease
1小时前
已完结
S1347 Examining the one-year adverse effects of immune checkpoint inhibitors among IBD patients with malignancies
1小时前
求助中
Sa1526 Impact and outcomes of extraintestinal immune-related adverse events in patients with inflammatory bowel diseases following immune checkpoint inhibitor therapy
1小时前
求助中
S1042 Gastrointestinal adverse events of immune checkpoint inhibitors in patients with inflammatory bowel disease: a multicenter collaborative network study
2小时前
求助中
S1014 Immune checkpoint inhibitors for colorectal cancer in patients with inflammatory bowel disease
2小时前
已完结
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases
3个月前
已完结
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study
5个月前
已完结
Risk factors and clinical course of inflammatory bowel disease in patients receiving cancer therapy
6个月前
已完结
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study
6个月前
已关闭
皖公网安备34019202002308
